Table 2 Baseline differences of Lab findings among responders and non-responders of Pegylated interferon α 2b and α 2a therapy
From: Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
Parameter | Pegylated interferon α 2b | P-value | Pegylated interferon α 2a | P-value | ||
|---|---|---|---|---|---|---|
Non-responders (n=10) | Responders (n=22) | Non-responders (n=13) | Responders (n=12) | |||
Age (Year) | 38.70 ± 9.76 | 37.27 ± 7.98 | 0.66 | 43.69 ± 5.76 | 40.75 ± 9.37 | 0.35 |
BMI** (Kg/m2) | 24.87 ± 4.63 | 27.02 ± 3.69 | 0.16 | 28.73 ± 3.99 | 26.93 ± 4.25 | 0.28 |
AST (0–42 IU/L) | 39.20 ± 25.68 | 64.15 ± 30.54 | 0.049* | 87.61 ± 43.13 | 37.83 ± 18.80 | 0.001* |
ALT (0–42 IU/L) | 44.12 ± 22.1 | 68.4 ± 21.1 | 0.07 | 46.42 ±14.13 | 43.56 ± 3.56 | 0.1 |
ALP (0–290 IU/L) | 16.53 ± 9.7 | 4.66 ± 7.51 | 0.041* | 13.94 ±15.38 | 4.24 ± 2.26 | 0.05* |
HCVPCR Log (EQ/ML) before treatment | 5.3082 | 5.4975 | 0.61 | 5.5034 | 5.1751 | 0.29 |